News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Foundation Accepting Applications for Prescription Drug Abuse Prevention Grants
03/24/2014

DUBLIN, Ohio, March 24, 2014 /PRNewswire/ -- The Cardinal Health Foundation is inviting non-profit organizations in 18 U.S. locations and Puerto Rico to apply for grant funding to support local efforts to prevent the abuse and misuse of prescription medications.

This marks the fifth consecutive year that the Cardinal Health Foundation's Prescription Drug Abuse and Misuse Prevention Grant Program will provide funding to help non-profit organizations raise awareness and promote education about this growing public health issue, at the local level.

This grant program is intended to reduce the misuse and abuse of prescription medications among youth, college students, adults and the elderly by supporting initiatives that seek to:

  • increase awareness of and willingness to openly discuss prescription drug abuse and its consequences;
  • increase knowledge of how to properly dispose of prescription medication; and
  • increase knowledge about how to reduce unlawful access to prescription drugs.

Registered 501(c)(3) organizations in the following locations are invited to apply for grants ranging from $5,000 - $15,000:

  • Albuquerque, N.M.
  • Atlanta, Ga.
  • Central Ohio
  • Delaware (all cities)
  • Denver, Colo.
  • El Paso, Texas
  • Hudson, Wis.
  • Lakeland/Tampa, Fla.
  • LaVergne, Tenn.
  • Little Rock, Ark.
  • Northeast Queens or Syracuse, N.Y.
  • Northern Chicago (Lake, McHenry and Kenosha counties)
  • Radcliff, Ky.
  • Puerto Rico
  • Seattle, Wash.
  • St. Louis, Mo.
  • Wheeling, W.Va.

Applicants are strongly encouraged to incorporate into their proposals the use of the comprehensive suite of GenerationRx prescription drug abuse awareness materials, developed by the Cardinal Health Foundation and The Ohio State University College of Pharmacy, which are available at www.cardinalhealth.com/generationrx. These materials provide health care providers, pharmacists, parents, teachers, youth group leaders and other concerned citizens unique, interactive resources to educate elementary-aged children, teens, college students, adults and the elderly about the realities and dangers of misusing and abusing prescription drugs.  

Interested applicants can find complete grant program criteria and can apply for grant funding online at www.cardinalhealth.com/community.The deadline for applications is April 25.

About the Cardinal Health Foundation
The Cardinal Health Foundation supports local, national and international programs that improve health care efficiency, effectiveness and excellence and the overall wellness of the communities where Cardinal Health's (NYSE: CAH) 30,000 employees live and work. The Cardinal Health Foundation also offers grants to encourage community service among its employees and works through international agencies to donate much-needed medical supplies and funding to those who need them in times of disaster. To learn more, visit www.cardinalhealth.com/community.

SOURCE Cardinal Health Foundation

For further information: Media: Corey Kerr, (614) 757-3383, corey.kerr@cardinalhealth.com; Investors: Sally Curley , (614) 757-7115, sally.curley@cardinalhealth.com
More Company News
04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

02/29/2024

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

View all company news »